Metabolomic investigation of cisplatin-induced acute kidney injury in paediatric cancer patients.
Saved in:
| Title: | Metabolomic investigation of cisplatin-induced acute kidney injury in paediatric cancer patients. |
|---|---|
| Authors: | Lim YJ; Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada., Thachil A; Division of Nephrology, Department of Pediatrics, British Columbia Children's Hospital, Vancouver, British Columbia, Canada., McMahon K; Department of Pediatrics, Division of Nephrology, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada., Tsuyuki RT; Epicore Center, Department of Medicine, Department of Pharmacology, University of Alberta, Edmonton, Alberta, Canada., Rassekh SR; Division of Oncology, Hematology and Bone Marrow Transplant, Department of Pediatrics, Faculty of Medicine, BC Children's Hospital and University of British Columbia, Vancouver, Canada., Mitchell LG; Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada., Devarajan P; Division of Nephrology and Hypertension, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA., Mammen C; Division of Nephrology, Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada., Carleton BC; Department of Medical Genetics, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada., Cuvelier GDE; Alberta Children's Hospital, University of Calgary, Calgary, Alberta, Canada., Lewis VA; Pediatric Oncology and Transplant, Alberta Children's Hospital, University of Calgary, Calgary, Alberta, Canada., Ross CJD; Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada., Zorzi AP; Division of Pediatric Hematology-Oncology, Children's Hospital London Health Sciences Centre, London, Ontario, Canada., Baruchel S; Translational Medicine, The Hospital for Sick Children Research Institute, University of Toronto, Toronto, Ontario, Canada., Ramphal R; Division of Hematology and Oncology, Department of Pediatrics, Children's Hospital of Eastern Ontario-Ottawa Children's Treatment Centre, Ottawa, Ontario, Canada., Bouffet E; Division of Nephrology, Department of Pediatrics, Hospital for Sick Children, Toronto, Ontario, Canada., Lemaire M; Division of Nephrology, Department of Pediatrics, Hospital for Sick Children, Toronto, Ontario, Canada., Blydt-Hansen TD; Division of Nephrology, Department of Pediatrics, British Columbia Children's Hospital, Vancouver, British Columbia, Canada., Urquhart BL; Department of Physiology and Pharmacology, Schulich School of Medicine & Dentistry, Western University, London, Ontario, Canada.; Division of Nephrology, Department of Medicine, Schulich School of Medicine & Dentistry, Western University, London, Ontario, Canada. |
| Corporate Authors: | Applying Biomarkers to Minimize Long‐Term Effects of Childhood/Adolescent Cancer Treatment (ABLE) Research Study Group |
| Source: | British journal of clinical pharmacology [Br J Clin Pharmacol] 2026 May 06, pp. e70587. Date of Electronic Publication: 2026 May 06. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7503323 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2125 (Electronic) Linking ISSN: 03065251 NLM ISO Abbreviation: Br J Clin Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
